There was no difference in albumin level [< 35/ ≥ 35 g/L: P = 0.846], possibly because hypoalbuminemia and ascites are interrelated indicators and influence one another, and that albumin supplementation therapy may lead to an increase in albumin levels (and thus, an improvement in C-P stage), but may not accurately reflect the liver’s ability to synthesize albumin. The gene discussed is ALB; the disease is Hypoalbuminemia.